<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355"><gtr:id>8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355</gtr:id><gtr:name>European Cooperation in Science and Technology (COST)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355"><gtr:id>8B7C8B1B-87E1-482C-B0C7-5C9D4EEE8355</gtr:id><gtr:name>European Cooperation in Science and Technology (COST)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1D87A983-C2BA-4D6B-8970-CF5BE6D67DF1"><gtr:id>1D87A983-C2BA-4D6B-8970-CF5BE6D67DF1</gtr:id><gtr:firstName>Vicky</gtr:firstName><gtr:surname>MacRae</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF023928%2F1"><gtr:id>8E93AF68-55CA-4B2F-A484-A04B7BC59B3B</gtr:id><gtr:title>Characterising novel mediators of vascular calcification.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/F023928/1</gtr:grantReference><gtr:abstractText>According to the World Health Organisation (WHO), an estimated 17 million people die each year of cardiovascular diseases, particularly heart attacks and strokes. A significant risk factor in the development of cardiovascular disease isVascular calcification. The process of vascular calcification shares many similarities with that of skeletal mineralisation, and involves the deposition of calcium phosphate mineral in arteries, heart valves, and cardiac muscle. Vascular calcification has severe clinical consequences, however, the mediators and mechanisms of vascular calcification have yet to be fully elucidated. A family of self-regulating proteins which alter the circulating levels of the hormone fibroblastic growth factor-23 (FGF23) have been recently shown to exert direct effects on skeletal mineralisation, along with FGF23 itself. These proteins include DMP1 (dentin matrix protein 1), PHEX (phosphate regulating neutral endopeptidase on chromosome X) and MEPE (matrix extracellular phosphoglycoprotein). This fellowship proposal will examine whether these newly discovered mediators of skeletal mineralisation also form a regulatory network in vascular calcification. Initially, the gene and protein expression patterns of FGF23, PHEX, DMP1 and MEPE will be determined during the calcification of vascular smooth muscle cells (VSMCs) (vascular calcification model) and compared to osteoblasts (skeletal mineralisation model). These observations will be confirmed in mice models of vascular calcification. Gene knockdown and over expression studies will investigate the function of FGF23, PHEX, DMP1 and MEPE in VSMCs and osteobasts. To discover the underpinning mechanisms, the regulation of key signaling pathways by FGF23, PHEX, DMP1 and MEPE during vascular calcification will be studied. To assess potential therapeuric strategies against vascular calcification, the study of novel inhibitors or inducers of FGF23, PHEX and DMP1 and MEPE will also be undertaken. Finally, a large scale analysis of all the genes and microRNAs (which can regulate the amount of protein expressed by the genes) altered during vascular calcification will be undertaken. This will identify new mediators of vascular calcification and potential therapeutic targets.</gtr:abstractText><gtr:technicalSummary>The process of vascular calcification (VC) shares many similarities with that of skeletal mineralisation, and involves the deposition of hydroxyapaptite crystals in arteries and cardiac muscle. VC has several clinical consequences, however, the mediators and mechanisms have yet to be fully elucidated. FGF23, DMP1, PHEX and MEPE have been recently shown to exert direct effects on skeletal mineralisation. This project will examine whether they also mediate vascular calcification. Expression patterns of FGF23, PHEX, DMP1 and MEPE will be Initially determined during the calcification of vascular smooth muscle cells (VSMCs) (VC model) and osteoblasts (skeletal mineralisation model) using quantitative PCR (qPCR) and immunoblotting. These observations will be confirmed by immunohistochemistry and in-situ hybridisation studies in enpp1-/- and ank/ank mice, in which VC is observed. To investigate FGF23, PHEX, DMP1 and MEPE function, microRNA and overexpression constructs will be cloned into the pSLIK lentiviral vector, permitting manipulation of gene expression at pre-determined time points during the culture period. This will allow the elucidation of the roles of these genes in both the initiation and propagation of calcification. Analysis of cell samples will include qPCR and immunoblotting. The calcification ability of matrix vesicles derived from the cell cultures will also be determined. To elucidate the underpinning mechanisms, the regulation of the Gas6/Axl, PI3kinase/Akt, ERK1/2, p38 MAPK and c-Jun N-terminal kinase signal transduction pathways by FGF23, PHEX, DMP1 and MEPE during VC will be studied in transfected cells. To assess potential therapeuric strategies against VC, inhibitors of DMP1 (DRB) and PHEX (MEPE-ASARM peptides) and an inducer of FGF23 (Dec-RVKR-CMK) will be studied in cells derived from enpp1-/- and ank/ank mice. Microarray and microRNA array systems analysis will identify novel mediators of VC and new potential therapeutic targets.</gtr:technicalSummary><gtr:fund><gtr:end>2016-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>915703</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Cooperation in Science and Technology (COST)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>COST Action</gtr:department><gtr:description>EuroSoftCalc European COST action</gtr:description><gtr:id>F72966FD-DCAF-43A9-AB05-67B4F0B3149B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c69bfc21c847.08546180-1</gtr:outcomeId><gtr:partnerContribution>Clinical, research and training expertise in rare diseases of calcification.</gtr:partnerContribution><gtr:piContribution>UK representative to the Management Committee and Working Group Leader (scientific exchanges and training)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Academic impact has been maximised primarily through peer-reviewed publications in high profile and open-access journals. To ensure that this dissemination was a dialogue with the scientific community, the academic impact has been augmented by presentations at national and international meetings. I have also prepared, displayed and manned exhibits on vascular calcification at the Roslin Institutes open doors days.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>071B57BF-2A59-47F9-8A39-989D45DC147B</gtr:id><gtr:impactTypes/><gtr:outcomeId>54553e1e249736.11187515</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>During this fellowship I have characterised and employed the ectonucleotide pyrophosphatase /phosphodiesterase-1 (Enpp1) null mouse model of aortic calcification to examine novel pathways involved in vascular calcification. I have made key contributions to the vascular field, including the identification of specific microRNAs, FGF-23, BMP-9, Phospho1, IGF2, and sclerostin as novel mediators of vascular calcification. Additionally, I have developed innovative protocols to image vascular calcification ex vivo using micro-computed tomography.</gtr:description><gtr:exploitationPathways>These findings have led to a better comprehension of the aetiology of vascular calcification, and may offer novel therapeutic strategies in the future.</gtr:exploitationPathways><gtr:id>C0CC7813-B1E9-4A1D-ABB9-9035CBEA265D</gtr:id><gtr:outcomeId>54553558cc0cb6.66859395</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B0CAC8F-31EC-47B1-AA3F-AA99EE594B2B</gtr:id><gtr:title>Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aa8ea677c586074a4e8cf459aa1b93"><gtr:id>94aa8ea677c586074a4e8cf459aa1b93</gtr:id><gtr:otherNames>Mackenzie NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_5435ade5ade5215cf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C15B1AA-D364-4C95-96AE-769A3F0048DB</gtr:id><gtr:title>MEPE is a novel regulator of growth plate cartilage mineralization.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a57ef0b0eae37b4dd694f0b683a15a0"><gtr:id>2a57ef0b0eae37b4dd694f0b683a15a0</gtr:id><gtr:otherNames>Staines KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_5435ade5ade703f77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAF898B7-80BC-4670-8C28-1784BCE75491</gtr:id><gtr:title>The role of cellular senescence during vascular calcification: a key paradigm in aging research.</gtr:title><gtr:parentPublicationTitle>Current aging science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aa8ea677c586074a4e8cf459aa1b93"><gtr:id>94aa8ea677c586074a4e8cf459aa1b93</gtr:id><gtr:otherNames>Mackenzie NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1874-6098</gtr:issn><gtr:outcomeId>543bda498e5be0.33614413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E2A8775-B617-44B1-8660-57D53AC9838B</gtr:id><gtr:title>Upregulation of IGF2 expression during vascular calcification.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>545359c8a37700.55767135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D83288F2-C30F-46D1-9465-A55AA40AE21C</gtr:id><gtr:title>A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.</gtr:title><gtr:parentPublicationTitle>Vascular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1537-1891</gtr:issn><gtr:outcomeId>585d36d02c9023.49472448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BB0D3BE-1D45-46E0-BCE0-144895D86C14</gtr:id><gtr:title>Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6912f9f5ad3a9d8a43a47001e6aca05d"><gtr:id>6912f9f5ad3a9d8a43a47001e6aca05d</gtr:id><gtr:otherNames>Hajjawi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>54535a3be31eb6.04146573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F1DC162-CEF9-40E4-A8E7-0398E4DD3CA0</gtr:id><gtr:title>Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf7065d49f817e3d827c139e14092e0c"><gtr:id>bf7065d49f817e3d827c139e14092e0c</gtr:id><gtr:otherNames>Lin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>5a748d483ec208.53598845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A50D0246-B0CD-4A1E-A021-7E8A931441E0</gtr:id><gtr:title>Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96ab390d1fc7367c19efddfe24af0059"><gtr:id>96ab390d1fc7367c19efddfe24af0059</gtr:id><gtr:otherNames>Kiffer-Moreira T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>54535bd54bd884.07477627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA8F0A87-C00F-4EAD-9686-7E4D10AAE53A</gtr:id><gtr:title>Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b7988e5ab37e5a7f52973c738cbe495"><gtr:id>7b7988e5ab37e5a7f52973c738cbe495</gtr:id><gtr:otherNames>Orriss IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn><gtr:outcomeId>54535a0e118425.93818126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C0D7DAC-93F5-485C-A56A-ECF62F8653A6</gtr:id><gtr:title>The role of cellular senescence during vascular calcification: a key paradigm in aging research</gtr:title><gtr:parentPublicationTitle>Current Aging Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f79e69906cc285fef66392ffef788647"><gtr:id>f79e69906cc285fef66392ffef788647</gtr:id><gtr:otherNames>Victoria MacRae (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>1874-6098</gtr:isbn><gtr:outcomeId>m_97712452651398cf7a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0D9E0B1-58B8-4183-89F6-5B14A522266A</gtr:id><gtr:title>Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0071e2671277b1e95579ea8d4649b02"><gtr:id>d0071e2671277b1e95579ea8d4649b02</gtr:id><gtr:otherNames>Huesa C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_55f93ba93baeba198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>077101C5-BF5F-4541-B162-4B5773E236AD</gtr:id><gtr:title>A protective role for FGF-23 in local defence against disrupted arterial wall integrity?</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>54535bb666b7f4.46947416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>163EA2D7-BCA3-4112-AD39-DF56EE7036F0</gtr:id><gtr:title>BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.</gtr:title><gtr:parentPublicationTitle>Journal of cellular and molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1582-1838</gtr:issn><gtr:outcomeId>5453596e990958.92343356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFFE7038-7F4B-418E-8D75-2860E9729BC6</gtr:id><gtr:title>Large animal models of cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Cell biochemistry and function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a161ddb7f22f040aadf99c8adb8c578"><gtr:id>7a161ddb7f22f040aadf99c8adb8c578</gtr:id><gtr:otherNames>Tsang HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0263-6484</gtr:issn><gtr:outcomeId>585d7188605796.23077397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45983C09-98B8-46C7-990D-946DEADFCEF7</gtr:id><gtr:title>New insights into NPP1 function: lessons from clinical and animal studies.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aa8ea677c586074a4e8cf459aa1b93"><gtr:id>94aa8ea677c586074a4e8cf459aa1b93</gtr:id><gtr:otherNames>Mackenzie NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_5435ade5ade79c42a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50AFA210-4BBD-4945-B347-A416CE0285AB</gtr:id><gtr:title>Mechanisms and clinical consequences of vascular calcification.</gtr:title><gtr:parentPublicationTitle>Frontiers in endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-2392</gtr:issn><gtr:outcomeId>pm_5435ade5ade5dcaf0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89BA5C56-950C-4D25-AC55-3BF394067ACB</gtr:id><gtr:title>Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a57ef0b0eae37b4dd694f0b683a15a0"><gtr:id>2a57ef0b0eae37b4dd694f0b683a15a0</gtr:id><gtr:otherNames>Staines KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0914-8779</gtr:issn><gtr:outcomeId>54535b7bb4ef33.70092862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE2827CF-792B-409B-9141-7707E6E9D3B4</gtr:id><gtr:title>Exploiting novel valve interstitial cell lines to study calcific aortic valve disease.</gtr:title><gtr:parentPublicationTitle>Molecular medicine reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a161ddb7f22f040aadf99c8adb8c578"><gtr:id>7a161ddb7f22f040aadf99c8adb8c578</gtr:id><gtr:otherNames>Tsang HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1791-2997</gtr:issn><gtr:outcomeId>5a8aafa1c07c48.17842693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A6A0300-4C36-4F4C-800D-565B3424FA23</gtr:id><gtr:title>Characterisation of matrix vesicles in skeletal and soft tissue mineralisation.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dd06aba8ba734c9caa61f1ea65fe749"><gtr:id>8dd06aba8ba734c9caa61f1ea65fe749</gtr:id><gtr:otherNames>Cui L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>585d3de1b81a76.90997715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F1C98BA-3555-46D7-9575-A1584F59F1CD</gtr:id><gtr:title>The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_5435ade5ade885528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>904541D6-903F-493F-8385-57F3E3CE40EB</gtr:id><gtr:title>The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a57ef0b0eae37b4dd694f0b683a15a0"><gtr:id>2a57ef0b0eae37b4dd694f0b683a15a0</gtr:id><gtr:otherNames>Staines KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>pm_53cc00bc00b7d58d3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FADC6E31-EDC9-453E-A90E-5C1CCB280651</gtr:id><gtr:title>Effects of etidronate on the Enpp1?/? mouse model of generalized arterial calcification of infancy.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0071e2671277b1e95579ea8d4649b02"><gtr:id>d0071e2671277b1e95579ea8d4649b02</gtr:id><gtr:otherNames>Huesa C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn><gtr:outcomeId>5675e47c875cc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F51033D3-EBDF-4C9D-9699-3C20A86FAAFC</gtr:id><gtr:title>Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d3de4e52855.61833775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39ECF16B-D57D-49EE-818B-90EB2306B070</gtr:id><gtr:title>A new method for the quantification of aortic calcification by three-dimensional micro-computed tomography.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0071e2671277b1e95579ea8d4649b02"><gtr:id>d0071e2671277b1e95579ea8d4649b02</gtr:id><gtr:otherNames>Huesa C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn><gtr:outcomeId>54535a82e115d2.54504414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D50F1203-C757-4690-9C7E-3161F826FAA4</gtr:id><gtr:title>miRNA-221 and miRNA-222 synergistically function to promote vascular calcification.</gtr:title><gtr:parentPublicationTitle>Cell biochemistry and function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aa8ea677c586074a4e8cf459aa1b93"><gtr:id>94aa8ea677c586074a4e8cf459aa1b93</gtr:id><gtr:otherNames>Mackenzie NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0263-6484</gtr:issn><gtr:outcomeId>54535a5d53a098.99892811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED46E950-7949-4B2F-A2A1-02B2CD7882B9</gtr:id><gtr:title>Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/123e9b7ae56710f81ded0d1e9e1e6a8b"><gtr:id>123e9b7ae56710f81ded0d1e9e1e6a8b</gtr:id><gtr:otherNames>Patel JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>5a8ab032dddc32.95040375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>615CF7A0-4BC8-418B-97E5-5B071EE9D363</gtr:id><gtr:title>MOVAS-1 cell line: a new in vitro model of vascular calcification.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94aa8ea677c586074a4e8cf459aa1b93"><gtr:id>94aa8ea677c586074a4e8cf459aa1b93</gtr:id><gtr:otherNames>Mackenzie NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn><gtr:outcomeId>543bda35ac22b8.71347216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCD6ED5D-58BC-44AD-A9C3-F5C233E21FE1</gtr:id><gtr:title>End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dd06aba8ba734c9caa61f1ea65fe749"><gtr:id>8dd06aba8ba734c9caa61f1ea65fe749</gtr:id><gtr:otherNames>Cui L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>5a2fd10263b5e4.47604360</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F023928/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>